• Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

Using Legal Authority Over An Aging Parent

July 11, 2025

Ford Recalls 850,000 Vehicles: What It Means for Your Safety and Your Finances

July 11, 2025

Mark Cuban Says AI Will Mint a Trillionaire. Start Your Climb Here

July 11, 2025
Facebook Twitter Instagram
Trending
  • Using Legal Authority Over An Aging Parent
  • Ford Recalls 850,000 Vehicles: What It Means for Your Safety and Your Finances
  • Mark Cuban Says AI Will Mint a Trillionaire. Start Your Climb Here
  • This Former NFL Player Built a Brand Around Nasal Breathing
  • What My First Failed Startup Taught Me — and How I Finally Got It Right 20 Years Later
  • The Best Domains Are Gone — Here’s How Savvy Founders Still Snag Them
  • Why Your Old Marketing Tactics Are Killing Your Growth in 2025
  • Mortgage rates tick higher for first time in weeks
Friday, July 11
Facebook Twitter Instagram
FintechoPro
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
FintechoPro
Home » FDA approves first-ever pill for postpartum depression in new mothers
Investing

FDA approves first-ever pill for postpartum depression in new mothers

News RoomBy News RoomAugust 6, 20230 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

The Food and Drug Administration late Friday approved the first-ever pill that can be taken at home for postpartum depression.

The medication, called zuranolone, and jointly developed by pharmaceutical companies Biogen Inc.
BIIB,
+0.44%
and Sage Therapeutics
SAGE,
+0.25%,
is taken daily for two weeks, the FDA said in its release.

In a pair of clinical trials involving women who experienced severe depression after having a baby, the drug improved symptoms including anxiety, trouble sleeping, loss of pleasure, low energy, guilt or social withdrawal as soon as three days after the first pill.

“Postpartum depression is a serious and potentially life-threatening condition in which women experience sadness, guilt, worthlessness — even, in severe cases, thoughts of harming themselves or their child,” said Tiffany Farchione, M.D., director of the Division of Psychiatry in the FDA’s Center for Drug Evaluation and Research.

”And, because postpartum depression can disrupt the maternal-infant bond, it can also have consequences for the child’s physical and emotional development,” she said.

Women who are breastfeeding or had mild or moderate depression weren’t included in the trials.

Until now, the only available option for this condition has been an intravenous injection that the FDA approved in 2019. It requires patients to stay in a hospital for two-and-a-half days.

Postpartum depression affects one in eight new mothers in the U.S., according to the Centers for Disease Control and Prevention. Researchers suggest the actual rate may be higher and that half of such cases go undiagnosed. 

Research finds that postpartum depression is more intense and lasts longer than the typical worries, sadness or tiredness that many women experience after giving birth. The condition can make it harder for mothers to bond with their babies and may increase the likelihood of developmental delays in infants.

Drug overdoses and suicides are leading causes of maternal death in the U.S., contributing to nearly one in four pregnancy-related deaths, according to the CDC. 

Zuranolone stimulates a brain receptor called GABA that slows down the brain and helps control anxiety and stress. The drug, through trials, is thought to calm women suffering from postpartum depression enough to allow them to rest, which also improves symptoms.

Shares of Biogen are up 23% over the past year, and Sage has lost 14%, while the S&P 500
SPX
is up 8% over the same time.

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

What My First Failed Startup Taught Me — and How I Finally Got It Right 20 Years Later

Investing July 10, 2025

He Went From Customer to CEO of 16 Handles

Investing July 9, 2025

Barbara Corcoran Retains Staff With Wild Perks, No Turnover

Investing July 8, 2025

Jack Dorsey Announces Bitchat Messaging App

Investing July 7, 2025

101 Small Business Ideas to Match Your Personality, Investment, Skills & Goals

Investing July 6, 2025

How to Deal With Negative Articles on Google

Investing July 5, 2025
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

Ford Recalls 850,000 Vehicles: What It Means for Your Safety and Your Finances

July 11, 20250 Views

Mark Cuban Says AI Will Mint a Trillionaire. Start Your Climb Here

July 11, 20251 Views

This Former NFL Player Built a Brand Around Nasal Breathing

July 10, 20250 Views

What My First Failed Startup Taught Me — and How I Finally Got It Right 20 Years Later

July 10, 20250 Views
Don't Miss

The Best Domains Are Gone — Here’s How Savvy Founders Still Snag Them

By News RoomJuly 10, 2025

Entrepreneur Getting a premium domain isn’t just a branding decision — it’s a strategic asset.…

Why Your Old Marketing Tactics Are Killing Your Growth in 2025

July 10, 2025

Mortgage rates tick higher for first time in weeks

July 10, 2025

Social Security & The Big Beautiful Bill

July 10, 2025
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 FintechoPro. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.